By: Madison Muller, Gerry Smith
Eli Lilly & Co. is on a record spending spree, announcing acquisitions worth more than $20 billion so far in 2026 as the drugmaker expands beyond its blockbuster obesity franchise.


Madison Muller is a Health Reporter at Bloomberg. She focuses on the intersections of medicine and healthcare, pharmaceuticals, healthcare technology, and health and wellness, covering topics such as consumer health, drugs and medication, and pharmaceutical regulation. Madison's work has been featured in prominent outlets including Yahoo Finance, Bloomberg Law, and The Washington Post.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)


Not enough data
Madison Muller's articles primarily focus on healthcare and pharmaceuticals, often referencing data and government announcements. She highlights news related to drug trials, pharmaceutical companies, and specific drugs' effects.
To effectively reach out to Madison, consider providing insights from industry experts or professionals with direct experience in the healthcare or pharmaceutical sectors. Given her reliance on data and government announcements, pitches backed by credible sources or studies may be particularly effective in capturing her attention.
It seems that Madison does not have a specific geographic focus but instead covers global developments within the healthcare and pharmaceutical industries. Therefore, when reaching out to her about industry trends or breaking news within these sectors, an international perspective could be valuable for your pitch.
This information evolves through artificial intelligence and human feedback. Improve this profile .